These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38295061)
1. Esketamine: Less Drowsiness, More Analgesia. Mion G; Himmelseher S Anesth Analg; 2024 Jul; 139(1):78-91. PubMed ID: 38295061 [TBL] [Abstract][Full Text] [Related]
2. Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine. Ma X; Peng J; Chen Y; Wang Z; Zhou Q; Yan J; Jiang H Dose Response; 2023; 21(1):15593258231157563. PubMed ID: 36798635 [TBL] [Abstract][Full Text] [Related]
3. Effects of esketamine sedation compared to morphine analgesia on hydrostatic reduction of intussusception: A case-cohort comparison study. van de Bunt JA; Veldhoen ES; Nievelstein RAJ; Hulsker CCC; Schouten ANJ; van Herwaarden MYA Paediatr Anaesth; 2017 Nov; 27(11):1091-1097. PubMed ID: 28940868 [TBL] [Abstract][Full Text] [Related]
4. Determining the effective dose of esketamine for mitigating pain during propofol injection by Dixon's up-and-down method: a double-blind, prospective clinical study of drug dose response. Tan M; Zhang C; Zeng W; Chen M; Huang Z; Huang D BMC Anesthesiol; 2022 Dec; 22(1):368. PubMed ID: 36457068 [TBL] [Abstract][Full Text] [Related]
6. Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine-But Not Esketamine-Induced Pain Relief. Dahan A; Jansen S; van der Schrier R; Sarton E; Dadiomov D; van Velzen M; Olofsen E; Niesters M ACS Pharmacol Transl Sci; 2024 Jul; 7(7):2044-2053. PubMed ID: 39022368 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study. Wang J; Huang J; Yang S; Cui C; Ye L; Wang SY; Yang GP; Pei Q Drug Des Devel Ther; 2019; 13():4135-4144. PubMed ID: 31827320 [TBL] [Abstract][Full Text] [Related]
8. Predicting efficacy of sub-anesthetic ketamine/esketamine i.v. dose during course of cesarean section for PPD prevention, utilizing traditional logistic regression and machine learning models. Li Q; Gao K; Yang S; Yang S; Xu S; Feng Y; Bai Z; Ping A; Luo S; Li L; Wang L; Shi G; Duan K; Wang S J Affect Disord; 2023 Oct; 339():264-270. PubMed ID: 37451434 [TBL] [Abstract][Full Text] [Related]
9. [Psychometric changes as well as analgesic action and cardiovascular adverse effects of ketamine racemate versus s-(+)-ketamine in subanesthetic doses]. Pfenninger E; Baier C; Claus S; Hege G Anaesthesist; 1994 Nov; 43 Suppl 2():S68-75. PubMed ID: 7840417 [TBL] [Abstract][Full Text] [Related]
10. Effect of different doses of esketamine compared with fentanyl combined with propofol on hypotension in patients undergoing painless abortion surgery: a prospective, randomized, double-blind controlled clinical trial. Chen J; Zou X; Hu B; Yang Y; Wang F; Zhou Q; Shen M BMC Anesthesiol; 2022 Sep; 22(1):305. PubMed ID: 36171562 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants]. Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380 [TBL] [Abstract][Full Text] [Related]
12. KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects. Harvey M; Sleigh J; Voss L; Bickerdike M; Dimitrov I; Denny W BMC Pharmacol Toxicol; 2019 Dec; 20(1):85. PubMed ID: 31856925 [TBL] [Abstract][Full Text] [Related]
14. Sub-anesthetic dose of esketamine decreases postoperative opioid self-administration after spine surgery: a retrospective cohort analysis. Zheng H; Zhang P; Shi S; Zhang X; Cai Q; Gong X Sci Rep; 2024 Feb; 14(1):3909. PubMed ID: 38365958 [TBL] [Abstract][Full Text] [Related]
15. [From the racemate to the eutomer: (S)-ketamine. Renaissance of a substance?]. Adams HA; Werner C Anaesthesist; 1997 Dec; 46(12):1026-42. PubMed ID: 9451486 [TBL] [Abstract][Full Text] [Related]
16. Research advances in the clinical application of esketamine. Zhang XX; Zhang NX; Liu DX; Ding J; Zhang YN; Zhu ZQ Ibrain; 2022; 8(1):55-67. PubMed ID: 37786420 [TBL] [Abstract][Full Text] [Related]
17. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. Smith-Apeldoorn SY; Veraart JKE; Kamphuis J; van Asselt ADI; Touw DJ; Aan Het Rot M; Schoevers RA BMC Psychiatry; 2019 Nov; 19(1):375. PubMed ID: 31783823 [TBL] [Abstract][Full Text] [Related]
18. Esketamine: A Novel Option for Treatment-Resistant Depression. Bozymski KM; Crouse EL; Titus-Lay EN; Ott CA; Nofziger JL; Kirkwood CK Ann Pharmacother; 2020 Jun; 54(6):567-576. PubMed ID: 31795735 [No Abstract] [Full Text] [Related]
19. Arketamine for cognitive impairment in psychiatric disorders. Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1513-1525. PubMed ID: 36786865 [TBL] [Abstract][Full Text] [Related]
20. Esketamine enhances memory reconsolidation in the novel object recognition task. Li H; Ying L; Wan F; Shiqiao K; Yijie F; Chuli X; Xudong Y; Xinhong Y; Zhiyong X Physiol Behav; 2024 Apr; 277():114461. PubMed ID: 38215863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]